Gene: LYG1
Official Full Name: lysozyme g1provided by HGNC
Gene Summary: Predicted to enable lysozyme activity. Predicted to be involved in defense response to Gram-positive bacterium. Predicted to be active in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26674 | LYG1 Knockout cell line (HCT 116) | Human | LYG1 | 1:2~1:4 | Negative | Online Inquiry |
KO26675 | LYG1 Knockout cell line (HEK293) | Human | LYG1 | 1:3~1:6 | Negative | Online Inquiry |
KO26676 | LYG1 Knockout cell line (A549) | Human | LYG1 | 1:3~1:4 | Negative | Online Inquiry |
LYG1 Gene Knockout Cell Lines are highly specialized cellular models genetically engineered to lack the expression of the LYG1 gene, which is implicated in various biological processes, including immune response and cellular signaling pathways. These cell lines are generated using advanced CRISPR/Cas9 technology, enabling precise and effective deletion of the targeted gene. The resulting knockout cells offer researchers an invaluable tool for dissecting the role of LYG1 in cellular functions and disease pathology.
The key functionality of LYG1 Gene Knockout Cell Lines lies in their ability to facilitate studies on gene function, cell signaling pathways, and the molecular mechanisms underlying diseases such as cancer and autoimmune disorders. By eliminating the LYG1 gene, researchers can observe phenotypic changes, perform rescue experiments, and assess the cellular response to treatments, thereby advancing our understanding of critical biological processes.
From a scientific perspective, these knockout cell lines are pivotal for research applications in genetic studies, pharmacology, and personalized medicine. They allow for targeted investigations that can lead to the identification of potential therapeutic targets, enhancing our ability to develop innovative strategies for treatment.
What sets LYG1 Gene Knockout Cell Lines apart from alternative models is their high specificity, reproducibility, and the ease with which they can be integrated into existing experimental frameworks. Researchers benefit from the clear, unambiguous results obtained from these knockout models, minimizing background effects associated with other genetic modifications.
For researchers and clinicians aiming to push the boundaries of knowledge in genetics, immunology, and translational medicine, LYG1 Gene Knockout Cell Lines present a vital resource. Their unique characteristics make them indispensable for those looking to elucidate the intricacies of LYG1's role in health and disease.
Our company specializes in the development of cutting-edge biological tools, ensuring our products meet the highest quality standards. With a commitment to supporting advanced scientific research, we pride ourselves on providing innovative solutions that empower researchers and drive discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.